• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺内淋巴结清扫术在病理分期 IA 期非小细胞肺癌中的临床意义:倾向评分匹配分析。

Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.

机构信息

Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, China.

Department of Thoracic Surgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.

出版信息

Thorac Cancer. 2021 May;12(10):1589-1597. doi: 10.1111/1759-7714.13955. Epub 2021 Apr 1.

DOI:10.1111/1759-7714.13955
PMID:33793088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8107027/
Abstract

BACKGROUND

This study aimed to investigate the prognostic impact of intrapulmonary lymph node (ILN, stations 13-14) dissection on disease-free survival (DFS) in stage IA non-small cell lung cancer (NSCLC) patients in order to facilitate a more suitable determination of surgical strategies for early-stage cases.

METHODS

We retrospectively analyzed 416 patients with pathological stage IA NSCLC from February 2016 to November 2019. The patients were divided into a group with ILN dissection (ILN group) and a group without ILN dissection (ILN group). DFS was compared using the Kaplan-Meier method and compared statistically using the log-rank test before and after propensity score matching (PSM). Subgroup analysis of DFS stratified based on tumor size was also calculated.

RESULTS

Both before and after PSM, the four-year DFS of the ILN group was greatly increased compared to that of ILN group (90.1% vs. 79.7%, p = 0.003; 95.5% vs. 80.6%, p = 0.003, respectively) and multivariable cox regression analysis revealed ILN dissection was an independent factor favoring DFS in stage IA NSCLC (p = 0.016 and p = 0.015, respectively). Subgroup analysis revealed the four-year DFS was comparable between the ILN and ILN groups with regard to tumor size ≤1.5 cm (90.6% vs. 92.7%, p = 0.715). However, the ILN group was found to have a better oncological outcome compared with the ILN group with regard to tumor size >1.5 cm (90.0% vs. 73.8%, p = 0.003).

CONCLUSIONS

The prognostic impact of ILN dissection on patients with stage IA NSCLC appears to be significantly influenced by tumor size, and this should be taken into account when choosing the most appropriate therapeutic modality.

摘要

背景

本研究旨在探讨在ⅠA 期非小细胞肺癌(NSCLC)患者中进行肺内淋巴结(stations 13-14,简称 ILN)清扫对无病生存(DFS)的预后影响,以便为早期病例制定更合适的手术策略。

方法

我们回顾性分析了 2016 年 2 月至 2019 年 11 月期间的 416 例病理分期为ⅠA 期 NSCLC 患者。将患者分为行 ILN 清扫(ILN 组)和未行 ILN 清扫(ILN 组)两组。采用 Kaplan-Meier 法比较两组患者的 DFS,并用对数秩检验比较倾向性评分匹配(PSM)前后的差异。同时还对基于肿瘤大小的 DFS 进行了亚组分析。

结果

PSM 前后,ILN 组的四年 DFS 均明显高于 ILN 组(90.1% vs. 79.7%,p = 0.003;95.5% vs. 80.6%,p = 0.003),多变量 Cox 回归分析表明,ILN 清扫是影响ⅠA 期 NSCLC 患者 DFS 的独立因素(p = 0.016 和 p = 0.015)。亚组分析显示,对于肿瘤大小≤1.5cm 的患者,ILN 组和 ILN 组的四年 DFS 无显著差异(90.6% vs. 92.7%,p = 0.715)。然而,对于肿瘤大小>1.5cm 的患者,ILN 组的肿瘤学预后明显优于 ILN 组(90.0% vs. 73.8%,p = 0.003)。

结论

ILN 清扫对ⅠA 期 NSCLC 患者的预后影响似乎受肿瘤大小显著影响,在选择最合适的治疗方式时应考虑这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/6496809d84d9/TCA-12-1589-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/406bb653d5aa/TCA-12-1589-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/39b4445bf030/TCA-12-1589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/e461bf224351/TCA-12-1589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/6496809d84d9/TCA-12-1589-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/406bb653d5aa/TCA-12-1589-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/39b4445bf030/TCA-12-1589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/e461bf224351/TCA-12-1589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae6/8107027/6496809d84d9/TCA-12-1589-g005.jpg

相似文献

1
Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.肺内淋巴结清扫术在病理分期 IA 期非小细胞肺癌中的临床意义:倾向评分匹配分析。
Thorac Cancer. 2021 May;12(10):1589-1597. doi: 10.1111/1759-7714.13955. Epub 2021 Apr 1.
2
[Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].[不同纵隔淋巴结清扫术对临床ⅠA期非小细胞肺癌的影响]
Zhonghua Wai Ke Za Zhi. 2008 May 1;46(9):670-3.
3
Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.临床I A期实性为主型非小细胞肺癌的肺叶特异性淋巴结清扫术:一项倾向评分匹配研究
Clin Lung Cancer. 2021 Mar;22(2):e201-e210. doi: 10.1016/j.cllc.2020.09.012. Epub 2020 Oct 15.
4
Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.肺内淋巴结取样缺失对无淋巴结转移肺癌患者预后评估的影响:倾向评分匹配分析。
Clin Lung Cancer. 2017 Nov;18(6):e411-e416. doi: 10.1016/j.cllc.2017.05.001. Epub 2017 May 11.
5
The effect of the extent of lymph node dissection for stage IA non-small-cell lung cancer on patient disease-free survival.淋巴结清扫范围对ⅠA 期非小细胞肺癌患者无病生存的影响。
Clin Lung Cancer. 2013 Mar;14(2):181-7. doi: 10.1016/j.cllc.2012.09.002. Epub 2012 Nov 27.
6
[The impact of uncertainty resection on the prognosis of non-small cell lung cancer].[不确定性切除对非小细胞肺癌预后的影响]
Zhonghua Wai Ke Za Zhi. 2024 Aug 1;62(8):764-770. doi: 10.3760/cma.j.cn112139-20240118-00035.
7
Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.肺叶特异性淋巴结清扫术作为非小细胞肺癌手术的标准程序:一项倾向评分匹配研究。
J Thorac Oncol. 2017 Jan;12(1):85-93. doi: 10.1016/j.jtho.2016.08.127. Epub 2016 Aug 20.
8
Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.3A 站淋巴结清扫术不能提高可手术的右侧非小细胞肺癌患者的长期生存率:一项倾向评分匹配研究。
Thorac Cancer. 2022 Aug;13(15):2106-2116. doi: 10.1111/1759-7714.14456. Epub 2022 Jun 15.
9
Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer.临床分期为IA期且病理分期为T1期的非小细胞肺癌患者行根治性系统性纵隔淋巴结清扫术与纵隔淋巴结采样术的比较
J Cancer Res Clin Oncol. 2008 Dec;134(12):1289-95. doi: 10.1007/s00432-008-0421-3. Epub 2008 May 27.
10
Does the extent of lymph nodes dissection affect the prognosis of resected stage IA non-small cell lung cancer?淋巴结清扫范围是否影响ⅠA 期可切除非小细胞肺癌的预后?
Clin Transl Oncol. 2014 Jan;16(1):77-84. doi: 10.1007/s12094-013-1043-z. Epub 2013 Apr 25.

引用本文的文献

1
N1-positive non-small cell lung cancer: surgeons' perspective before undertaking a major resection.N1 阳性非小细胞肺癌:外科医生在进行大手术切除前的观点。
Indian J Thorac Cardiovasc Surg. 2024 May;40(3):353-356. doi: 10.1007/s12055-024-01724-7. Epub 2024 Mar 27.
2
CORRIGENDUM.勘误
Thorac Cancer. 2022 Jun;13(11):1747. doi: 10.1111/1759-7714.14467.

本文引用的文献

1
Adjuvant chemotherapy may improve outcome of patients with non-small-cell lung cancer with metastasis of intrapulmonary lymph nodes after systematic dissection of N1 nodes.辅助化疗可能改善在系统性清扫N1淋巴结后出现肺内淋巴结转移的非小细胞肺癌患者的预后。
Chin J Cancer Res. 2018 Dec;30(6):588-595. doi: 10.21147/j.issn.1000-9604.2018.06.03.
2
Long-Term Prognosis After Segmentectomy for cT1 N0 M0 Non-Small Cell Lung Cancer.cT1N0M0 期非小细胞肺癌行解剖性肺段切除术的长期预后。
Ann Thorac Surg. 2019 May;107(5):1500-1506. doi: 10.1016/j.athoracsur.2018.11.046. Epub 2018 Dec 21.
3
Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas.
肺段切除术与肺叶切除术在高代谢临床ⅠA 期肺腺癌中的等效性。
Ann Thorac Surg. 2019 Jan;107(1):217-223. doi: 10.1016/j.athoracsur.2018.07.042. Epub 2018 Sep 19.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.肺段切除术与肺叶切除术治疗 2cm 或以下早期非小细胞肺癌的对比:一项基于人群的研究。
Respirology. 2018 Jul;23(7):695-703. doi: 10.1111/resp.13277. Epub 2018 Feb 21.
6
VATS segmentectomy: past, present, and future.电视辅助胸腔镜手术肺段切除术:过去、现在与未来
Gen Thorac Cardiovasc Surg. 2018 Feb;66(2):81-90. doi: 10.1007/s11748-017-0878-6. Epub 2017 Dec 18.
7
Differences in postoperative changes in pulmonary functions following segmentectomy compared with lobectomy.与肺叶切除术相比,节段切除术对肺功能术后变化的影响存在差异。
Eur J Cardiothorac Surg. 2018 Mar 1;53(3):640-647. doi: 10.1093/ejcts/ezx357.
8
[Importance of segmental lymph nodes in the pathological staging of non-small cell lung cancer].[肺段淋巴结在非小细胞肺癌病理分期中的重要性]
Zhonghua Yi Xue Za Zhi. 2017 Jun 13;97(22):1714-1718. doi: 10.3760/cma.j.issn.0376-2491.2017.22.008.
9
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌临床实践指南(2017 年第 5 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2017 Apr;15(4):504-535. doi: 10.6004/jnccn.2017.0050.
10
Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.肺癌——美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Mar;67(2):138-155. doi: 10.3322/caac.21390. Epub 2017 Jan 31.